|
YBGJ Yubo International Biotech Ltd 895464 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-247,949.00 |
| Balance Sheet |
|
Current Assets
|
$583,098.00 |
|
Assets
|
$672,272.00 |
|
Current Liabilities
|
$3,327,598.00 |
|
Liabilities
|
$3,327,598.00 |
|
Equity
|
$-2,622,591.00 |
|
Shares Out
|
170416343.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-291,261.00 |
| Market Analysis |
Market Cap
|
$1,704,163.43 |
|
Price
|
$0.01 |
|
PB
|
0.02 |
|
FCF
|
$-291,261.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:05 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:55 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view YBGJ documents filed with the SEC.
YBGJ Filings
Clear
